{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:22:43Z","timestamp":1792740163362,"version":"4.5.0"},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T00:00:00Z","timestamp":1095811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p><jats:bold>BACKGROUND:\u2002<\/jats:bold>Bacterial contamination of platelet (PLT) concentrates can result in transfusion\u2010transmitted sepsis. A photochemical treatment (PCT) process with amotosalen HCl and long\u2010wavelength ultraviolet light (UVA), which cross\u2010links nucleic acids, was developed to inactivate bacteria and other pathogens in PLT concentrates.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold>High titers of pathogenic aerobic and anaerobic Gram\u2010positive bacteria (10 species), aerobic Gram\u2010negative bacteria (7 species), and spirochetes (2 species) were added to single\u2010donor PLT concentrates containing 3.0\u2003\u00d7\u200310<jats:sup>11<\/jats:sup>to 6.0\u2003\u00d7\u200310<jats:sup>11<\/jats:sup>PLTs in approximately 300\u2003mL of 35\u2003percent plasma and 65\u2003percent PLT additive solution (InterSol, Baxter Healthcare) or saline. After PCT with 150\u2003\u00b5mol per L amotosalen and 3\u2003J per cm<jats:sup>2<\/jats:sup>UVA, residual bacterial levels were detected by sensitive microbiologic methods.<\/jats:p><jats:p><jats:bold>RESULTS:\u2002<\/jats:bold>The level of inactivation of viable bacteria was expressed as log reduction. Log reduction of Gram\u2010positive bacteria for<jats:italic>Staphylococcus epidermidis<\/jats:italic>was &gt;\u200a6.6; for<jats:italic>Staphylococcus aureus,<\/jats:italic>6.6; for<jats:italic>Streptococcus pyogenes,<\/jats:italic>&gt;\u200a6.8; for<jats:italic>Listeria monocytogenes,<\/jats:italic>&gt;\u200a6.3; for<jats:italic>Corynebacterium minutissimum,<\/jats:italic>&gt;\u200a6.3; for<jats:italic>Bacillus cereus<\/jats:italic>(vegetative), &gt;\u20035.5; for<jats:italic>Lactobacillus<\/jats:italic>sp., &gt;\u200a6.4; for<jats:italic>Bifidobacterium adolescentis,<\/jats:italic>&gt;\u200a6.0; for<jats:italic>Propionibacterium acnes,<\/jats:italic>&gt;\u200a6.2; and for<jats:italic>Clostridium perfringens,<\/jats:italic>&gt;\u200a6.5. Log reduction of Gram\u2010negative bacteria for<jats:italic>Escherichia coli<\/jats:italic>was &gt;\u200a6.4; for<jats:italic>Serratia marcescens,<\/jats:italic>&gt;\u200a6.7; for<jats:italic>Klebsiella pneumoniae,<\/jats:italic>&gt;\u200a5.6; for<jats:italic>Pseudomonas aeruginosa,<\/jats:italic>4.5; for<jats:italic>Salmonella choleraesuis,<\/jats:italic>&gt;\u200a6.2; for<jats:italic>Yersinia enterocolitica,<\/jats:italic>&gt;\u20035.9; and for<jats:italic>Enterobacter cloacae,<\/jats:italic>5.9. Log reduction of spirochetes for<jats:italic>Treponema pallidum<\/jats:italic>was 6.8 to 7.0, and for<jats:italic>Borrelia burgdorferi,<\/jats:italic>&gt;\u200a6.9.<\/jats:p><jats:p><jats:bold>CONCLUSION:\u2002<\/jats:bold>PCT inactivates high levels of a broad spectrum of pathogenic bacteria. The inactivation of bacteria in PLT concentrates offers the potential to prospectively prevent PLT\u2010transfusion\u2010associated bacteremia.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2004.04125.x","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T09:53:43Z","timestamp":1095846823000},"page":"1496-1504","source":"Crossref","is-referenced-by-count":144,"title":["Photochemical treatment of platelet concentrates with amotosalen and long\u2010wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria"],"prefix":"10.1111","volume":"44","author":[{"given":"Lily","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Dikeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Molini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila A.","family":"Lukehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Metzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Corash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,22]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30790385515.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41121493.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(91)70194-6"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470040119033"},{"key":"e_1_2_7_6_2","first-page":"59","article-title":"Incidence and significance of the bacterial contamination of blood components","volume":"108","author":"Blajchman MA","year":"2002","journal-title":"Dev Biol"},{"key":"e_1_2_7_7_2","unstructured":"HillyerC JosephsonC BlajchmanM et al.Bacterial contamination of blood components: risk strategies and regulation: joint ASH and AABB educational session in transfusion medicine.Hematol (Am Soc Hematol Educ Prog)2003:575\u201089."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.341195065031.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2003.10.002"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90290-1"},{"key":"e_1_2_7_11_2","first-page":"31","volume-title":"Bacterial and parasitic contamination of blood components","author":"Goldman M","year":"2003"},{"issue":"1","key":"e_1_2_7_12_2","first-page":"S326","article-title":"Four\u2010year experience with routine bacterial screening of platelet concentrates","volume":"1","author":"Claeys H","year":"2003","journal-title":"J Blood Banks Transfus Soc Turkey VIII European Congress Int Soc Blood Transfus"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37497265344.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90118-0"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2000.7840209.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0932"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2698.2698"},{"key":"e_1_2_7_18_2","first-page":"493","article-title":"A simple method of estimating fifty\u2010per cent endpoints","volume":"27","author":"Reed LJ","year":"1938","journal-title":"Am J Hyg"},{"key":"e_1_2_7_19_2","first-page":"247","article-title":"Note for Guidance: Validation of virus removal and inactivation procedures. Committee for proprietary medicinal products. Ad Hoc Working Party on Biotechnology\/Pharmacy and Working Party on Safety Medicines","volume":"19","author":"EEC Regulatory Document.","year":"1991","journal-title":"Biologicals"},{"key":"e_1_2_7_20_2","first-page":"1","article-title":"The minimal infectious inoculum of Spirochaeta pallida (Nichols Strain), and a consideration of its rate of multiplication in vivo","volume":"32","author":"Magnuson H","year":"1948","journal-title":"Am J Syphilis, Gonorrhea Venereal Dis"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00174.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400606"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00481.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3143"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0762"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000053391"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.475-479.2003"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2180"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704284"},{"key":"e_1_2_7_30_2","first-page":"92S","article-title":"The INTERCEPT blood system for platelets inactivates anaerobic bacteria","volume":"42","author":"Savoor AR","year":"2002","journal-title":"Transfusion"},{"issue":"2","key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1423-0410.2000.tb00065.x","article-title":"The use of riboflavin for the inactivation of pathogens in blood products","volume":"78","author":"Goodrich RP","year":"2000","journal-title":"Vox Sang"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00270.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41040477.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40111308.x"},{"key":"e_1_2_7_35_2","first-page":"74s","article-title":"Bacterial surveillance of platelet concentrates: quantitation of bacterial load","volume":"37","author":"Blajchman MA","year":"1997","journal-title":"Transfusion"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00023.x"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41081069.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2004.04125.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2004.04125.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2004.04125.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:09:38Z","timestamp":1734545378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2004.04125.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,22]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1537-2995.2004.04125.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2004.04125.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,22]]}}}